Skip to main content

Displaying 1 - 20 of 101

Precision Patient Outcomes

In November 2022, the FTC filed a complaint in court seeing civil penalties against California-based Precision Patient Outcomes, Inc. and the company’s CEO Margrett Priest Lewis for marketing an over-the-counter dietary supplement containing nothing more than vitamins, zinc, and a flavonoid as an effective treatment to mitigate the effects of COVID-19. In February 2024, the FTC announced an order settling its allegations that bars the defendants from the alleged deceptive practices.

Type of Action
Federal
Last Updated
FTC Matter/File Number
2123137
Case Status
Pending